Scarica l'app Stockscreener
39.69
0.43%
-0.17
Dopo l'orario di chiusura:
39.69
Precedente Chiudi:
$39.86
Aprire:
$39.7
Volume 24 ore:
3.65M
Relative Volume:
1.61
Capitalizzazione di mercato:
$6.14B
Reddito:
$15.06M
Utile/perdita netta:
$-197.82M
Rapporto P/E:
-27.24
EPS:
-1.4568
Flusso di cassa netto:
$-194.64M
1 W Prestazione:
+35.00%
1M Prestazione:
+49.72%
6M Prestazione:
+72.19%
1 anno Prestazione:
+189.71%
Intervallo 1D:
$39.65
$39.82
Intervallo di 1 settimana:
$27.33
$40.26
Portata 52W:
$9.60
$40.26
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Nome
Centessa Pharmaceuticals Plc Adr
Settore
Industria
Telefono
44 7391 789784
Indirizzo
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
39.69 | 6.14B | 15.06M | -197.82M | -194.64M | -1.4568 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-24 | Iniziato | Wolfe Research | Outperform |
| 2025-12-10 | Ripresa | Oppenheimer | Outperform |
| 2025-10-28 | Iniziato | Stephens | Overweight |
| 2025-09-03 | Iniziato | Wells Fargo | Overweight |
| 2025-08-29 | Ripresa | Oppenheimer | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-05-08 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-31 | Iniziato | Piper Sandler | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-07-18 | Iniziato | Oppenheimer | Outperform |
| 2023-11-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-10-26 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Iniziato | Evercore ISI | Outperform |
| 2023-06-12 | Iniziato | Guggenheim | Buy |
| 2023-03-17 | Iniziato | SVB Securities | Outperform |
| 2022-08-12 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-02-11 | Iniziato | Goldman | Neutral |
Mostra tutto
Centessa Pharmaceuticals Plc Adr Borsa (CNTA) Ultime notizie
Free cash flow per share of Centessa Pharmaceuticals PLC ADR – MUN:260 - TradingView
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Benzinga
This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) - Sahm
Centessa Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CNTA) - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal - MSN
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal - Yahoo Finance
JPMorgan Chase & Co. Sells 186,539 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
SG Americas Securities LLC Buys 240,039 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 40.03 USD By Investing.com - Investing.com South Africa
Weight-Loss Drug Giant Eli Lilly Bets Big Again. Spending $7.8 Billion to Acquire Centessa, Is Now a Good Time to Buy Eli Lilly? - TradingKey
Lilly (NYSE: LLY) buying Centessa (NASDAQ: CNTA) for $38 plus CVR - Stock Titan
Options Traders Pick Up Pharma Stock After Eli Lilly Buyout - Finviz
Gold Gains Over 1%; FactSet Research Raises FY2026 OutlookApellis Pharmaceuticals (NASDAQ:APLS), Cente - Benzinga
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders - Barchart.com
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders? - Finviz
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Eli Lilly (LLY) Stock Rises as Company Agrees to Buy Centessa in $6.3 Billion Sleep Drug Deal - MEXC Exchange
Centessa Pharmaceuticals stock hits all-time high at 40.03 USD - Investing.com
禮來(LLY.US)將以高達78億美元收購安眠藥生產商Centessa(CNTA.US) 後者股價盤前飆升46% - AASTOCKS.com
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders - ChartMill
This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Sahm
Karen Anderson Sells 41,076 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - defenseworld.net
Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 7%Here's Why - MarketBeat
41,076 ADS proposed for sale by affiliate (NASDAQ: CNTA) — Form 144 - Stock Titan
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 64,768 Shares - MarketBeat
Karen Anderson Sells 10,043 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Karen M. Anderson sells ADRs; CNTA (NASDAQ: CNTA) Form 144 notice - Stock Titan
Cinctive Capital Management LP Purchases New Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
[144] Centessa Pharmaceuticals plc SEC Filing - Stock Titan
First Light Asset Management LLC Sells 657,595 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Holdings Cut by Commodore Capital LP - MarketBeat
Centessa Pharmaceuticals CEO Touts ORX750 as Best-in-Class as Registration Studies Nearing Start - Yahoo Finance
Avoro Capital Advisors LLC Buys 5,808,080 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Gregory Weinhoff Sells 73,196 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 120,029 Shares - MarketBeat
CNTA (NASDAQ: CNTA) insider files Form 144 to sell 120,029 ADRs valued $3.10M - Stock Titan
Capital World Investors Has $16.61 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Has $27.08 Million Stock Position in BJ’s Restaurants, Inc. $BJRI - Defense World
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference - Yahoo Finance
Blue Owl Capital Holdings LP Reduces Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Royce & Associates LP Acquires New Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
CNTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TD Asset Management Inc Trims Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - AOL.com
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Aberdeen Group plc - Defense World
Centessa Pharmaceuticals Plc Adr Azioni (CNTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):